Interestingly, the prevention of LD accumulation in Elovl5-silenced MCF-7 cells by a treatment with DGAT1 inhibitor reduced lung metastases in mice highlighting a therapeutic role of anti-lipid-droplet drugs against breast cancer metastasis. Here, DGAT1 is linked to breast cancer.